Analyst Coverage

We lead the synthetic biology industry, having developed and successfully commercialized the most Lab-to-Market™ ingredients. Our sustainable ingredients are used in thousands of top global brands, including our own family of consumer brands in Clean Beauty and Health markets.

Amyris is covered by the following analysts.


Firm Analyst

Steven Mah


Laurence Alexander

Oppenheimer & Co.

Colin Rusch

H.C. Wainwright

Amit Dayal

J.P. Morgan

Rachel Vatnsdal
Piper Sandler

Korinne Wolfmeyer

Roth Capital Partners

Craig Irwin

Amyris is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Amyris's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Amyris or its management. Amyris does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.